187 related articles for article (PubMed ID: 21303838)
1. Antiphospholipid Syndrome Clinical Research Task Force report.
Erkan D; Derksen R; Levy R; Machin S; Ortel T; Pierangeli S; Roubey R; Lockshin M
Lupus; 2011 Feb; 20(2):219-24. PubMed ID: 21303838
[TBL] [Abstract][Full Text] [Related]
2. 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
Pierangeli SS; de Groot PG; Dlott J; Favaloro E; Harris EN; Lakos G; Ortel T; Meroni PL; Otomo K; Pengo V; Tincani A; Wong R; Roubey R
Lupus; 2011 Feb; 20(2):182-90. PubMed ID: 21303835
[TBL] [Abstract][Full Text] [Related]
3. 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.
Bertolaccini ML; Amengual O; Atsumi T; Binder WL; de Laat B; Forastiero R; Kutteh WH; Lambert M; Matsubayashi H; Murthy V; Petri M; Rand JH; Sanmarco M; Tebo AE; Pierangeli SS
Lupus; 2011 Feb; 20(2):191-205. PubMed ID: 21303836
[TBL] [Abstract][Full Text] [Related]
4. Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010.
Branch W;
Lupus; 2011 Feb; 20(2):158-64. PubMed ID: 21303832
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies.
Ruiz-Irastorza G; Cuadrado MJ; Ruiz-Arruza I; Brey R; Crowther M; Derksen R; Erkan D; Krilis S; Machin S; Pengo V; Pierangeli S; Tektonidou M; Khamashta M
Lupus; 2011 Feb; 20(2):206-18. PubMed ID: 21303837
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the 2006 revised antiphospholipid syndrome classification criteria.
Kaul M; Erkan D; Sammaritano L; Lockshin MD
Ann Rheum Dis; 2007 Jul; 66(7):927-30. PubMed ID: 17337473
[TBL] [Abstract][Full Text] [Related]
7. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
Lupus; 2011 Feb; 20(2):165-73. PubMed ID: 21303833
[TBL] [Abstract][Full Text] [Related]
8. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
Lupus; 2011 Feb; 20(2):174-81. PubMed ID: 21303834
[TBL] [Abstract][Full Text] [Related]
9. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.
de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW
Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
12. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
14. The Ped-APS Registry: the antiphospholipid syndrome in childhood.
Avcin T; Cimaz R; Rozman B;
Lupus; 2009 Sep; 18(10):894-9. PubMed ID: 19671789
[TBL] [Abstract][Full Text] [Related]
15. Management of the neurological manifestations of APS--what do the trials tell us?
Brey RL
Thromb Res; 2004; 114(5-6):489-99. PubMed ID: 15507283
[TBL] [Abstract][Full Text] [Related]
16. Recurrent early pregnancy loss and antiphospholipid antibodies: where do we stand?
Wong LF; Porter TF; de Jesús GR
Lupus; 2014 Oct; 23(12):1226-8. PubMed ID: 25228711
[TBL] [Abstract][Full Text] [Related]
17. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').
Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA
Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349
[TBL] [Abstract][Full Text] [Related]
19. 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome.
Sciascia S; Radin M; Cecchi I; Levy RA; Erkan D
Lupus; 2021 Jul; 30(8):1314-1326. PubMed ID: 34039107
[TBL] [Abstract][Full Text] [Related]
20. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.
Erkan D; Espinosa G; Cervera R
Autoimmun Rev; 2010 Dec; 10(2):74-9. PubMed ID: 20696282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
